Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls

Alison J. Dawson, Thozhukat Sathyapalan, Peter Sedman, Ramzi Ajjan, Eric S. Kilpatrick, Stephen Atkin

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background Insulin resistance (IR) after bariatric surgery is significantly lower than controls matched for bodymass index (BMI) and is indistinguishable from lean subjects however it is not known if this is the same for associated cardiovascular risk (CVR) markers (endothelial function (EF) and clot structure and function (maximum absorbance (MA) lysis potential (LT) and clot formation time (FT). Objective We sought to determine if IR and associated CVR markers one year after bariatric surgery were comparable to post surgery age and BMI matched controls. Methods Ten patients had before and 12 months after Rouxen- Y surgery CVR measurements compared to controls Results BMI reduced after surgery to 33.3 ±1.7 kg/m2 p<0.001 comparable to controls 32.6 ±1.6 kg/m2 p=0.87. Fasting glucose reduced after surgery to 4.6 ±0.1 mmol/L, lower than controls 5.0 ±0.1 mmol/L p=0.03. IR (calculated using HOMA-IR) reduced 0.77 ±0.14 p=0.03 and was lower than controls 2.35 ±0.32 p= 0.02. Systolic blood pressure (BP) reduced to 114.2 ±3.6 mmHg which was lower than controls 127.7 ±4.1 mmHg p=0.04, but diastolic BP was unaffected by surgery and no different to controls. EF, hsCRP and HDLcholesterol improved after surgery and did not differ to controls. Markers of blood clotting: MA and FT were unaffected by surgery and no different to controls, LT improved after surgery 3078 ±580 to 1665 ±330s p= 0.04) and was no different to controls (2088 ±556s p=0.12) Conclusions Bariatric surgery improved cardiovascular risk parameters to that of the equivalent controls post surgery for weight including EF, hsCRP and LT supporting bariatric surgery as an effective management of obesity.

Original languageEnglish
Pages (from-to)349-358
Number of pages10
JournalObesity Surgery
Volume24
Issue number3
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Bariatric Surgery
Morbid Obesity
Insulin Resistance
Weights and Measures
Blood Pressure
Blood Coagulation
Fasting
Obesity
Glucose

Keywords

  • Endothelial function
  • Insulin resistance
  • Obesity
  • Roux-en-Y surgery

ASJC Scopus subject areas

  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls. / Dawson, Alison J.; Sathyapalan, Thozhukat; Sedman, Peter; Ajjan, Ramzi; Kilpatrick, Eric S.; Atkin, Stephen.

In: Obesity Surgery, Vol. 24, No. 3, 2014, p. 349-358.

Research output: Contribution to journalArticle

Dawson, Alison J. ; Sathyapalan, Thozhukat ; Sedman, Peter ; Ajjan, Ramzi ; Kilpatrick, Eric S. ; Atkin, Stephen. / Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls. In: Obesity Surgery. 2014 ; Vol. 24, No. 3. pp. 349-358.
@article{a870100169584eb5a9072fc79b541670,
title = "Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls",
abstract = "Background Insulin resistance (IR) after bariatric surgery is significantly lower than controls matched for bodymass index (BMI) and is indistinguishable from lean subjects however it is not known if this is the same for associated cardiovascular risk (CVR) markers (endothelial function (EF) and clot structure and function (maximum absorbance (MA) lysis potential (LT) and clot formation time (FT). Objective We sought to determine if IR and associated CVR markers one year after bariatric surgery were comparable to post surgery age and BMI matched controls. Methods Ten patients had before and 12 months after Rouxen- Y surgery CVR measurements compared to controls Results BMI reduced after surgery to 33.3 ±1.7 kg/m2 p<0.001 comparable to controls 32.6 ±1.6 kg/m2 p=0.87. Fasting glucose reduced after surgery to 4.6 ±0.1 mmol/L, lower than controls 5.0 ±0.1 mmol/L p=0.03. IR (calculated using HOMA-IR) reduced 0.77 ±0.14 p=0.03 and was lower than controls 2.35 ±0.32 p= 0.02. Systolic blood pressure (BP) reduced to 114.2 ±3.6 mmHg which was lower than controls 127.7 ±4.1 mmHg p=0.04, but diastolic BP was unaffected by surgery and no different to controls. EF, hsCRP and HDLcholesterol improved after surgery and did not differ to controls. Markers of blood clotting: MA and FT were unaffected by surgery and no different to controls, LT improved after surgery 3078 ±580 to 1665 ±330s p= 0.04) and was no different to controls (2088 ±556s p=0.12) Conclusions Bariatric surgery improved cardiovascular risk parameters to that of the equivalent controls post surgery for weight including EF, hsCRP and LT supporting bariatric surgery as an effective management of obesity.",
keywords = "Endothelial function, Insulin resistance, Obesity, Roux-en-Y surgery",
author = "Dawson, {Alison J.} and Thozhukat Sathyapalan and Peter Sedman and Ramzi Ajjan and Kilpatrick, {Eric S.} and Stephen Atkin",
year = "2014",
doi = "10.1007/s11695-013-1100-2",
language = "English",
volume = "24",
pages = "349--358",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls

AU - Dawson, Alison J.

AU - Sathyapalan, Thozhukat

AU - Sedman, Peter

AU - Ajjan, Ramzi

AU - Kilpatrick, Eric S.

AU - Atkin, Stephen

PY - 2014

Y1 - 2014

N2 - Background Insulin resistance (IR) after bariatric surgery is significantly lower than controls matched for bodymass index (BMI) and is indistinguishable from lean subjects however it is not known if this is the same for associated cardiovascular risk (CVR) markers (endothelial function (EF) and clot structure and function (maximum absorbance (MA) lysis potential (LT) and clot formation time (FT). Objective We sought to determine if IR and associated CVR markers one year after bariatric surgery were comparable to post surgery age and BMI matched controls. Methods Ten patients had before and 12 months after Rouxen- Y surgery CVR measurements compared to controls Results BMI reduced after surgery to 33.3 ±1.7 kg/m2 p<0.001 comparable to controls 32.6 ±1.6 kg/m2 p=0.87. Fasting glucose reduced after surgery to 4.6 ±0.1 mmol/L, lower than controls 5.0 ±0.1 mmol/L p=0.03. IR (calculated using HOMA-IR) reduced 0.77 ±0.14 p=0.03 and was lower than controls 2.35 ±0.32 p= 0.02. Systolic blood pressure (BP) reduced to 114.2 ±3.6 mmHg which was lower than controls 127.7 ±4.1 mmHg p=0.04, but diastolic BP was unaffected by surgery and no different to controls. EF, hsCRP and HDLcholesterol improved after surgery and did not differ to controls. Markers of blood clotting: MA and FT were unaffected by surgery and no different to controls, LT improved after surgery 3078 ±580 to 1665 ±330s p= 0.04) and was no different to controls (2088 ±556s p=0.12) Conclusions Bariatric surgery improved cardiovascular risk parameters to that of the equivalent controls post surgery for weight including EF, hsCRP and LT supporting bariatric surgery as an effective management of obesity.

AB - Background Insulin resistance (IR) after bariatric surgery is significantly lower than controls matched for bodymass index (BMI) and is indistinguishable from lean subjects however it is not known if this is the same for associated cardiovascular risk (CVR) markers (endothelial function (EF) and clot structure and function (maximum absorbance (MA) lysis potential (LT) and clot formation time (FT). Objective We sought to determine if IR and associated CVR markers one year after bariatric surgery were comparable to post surgery age and BMI matched controls. Methods Ten patients had before and 12 months after Rouxen- Y surgery CVR measurements compared to controls Results BMI reduced after surgery to 33.3 ±1.7 kg/m2 p<0.001 comparable to controls 32.6 ±1.6 kg/m2 p=0.87. Fasting glucose reduced after surgery to 4.6 ±0.1 mmol/L, lower than controls 5.0 ±0.1 mmol/L p=0.03. IR (calculated using HOMA-IR) reduced 0.77 ±0.14 p=0.03 and was lower than controls 2.35 ±0.32 p= 0.02. Systolic blood pressure (BP) reduced to 114.2 ±3.6 mmHg which was lower than controls 127.7 ±4.1 mmHg p=0.04, but diastolic BP was unaffected by surgery and no different to controls. EF, hsCRP and HDLcholesterol improved after surgery and did not differ to controls. Markers of blood clotting: MA and FT were unaffected by surgery and no different to controls, LT improved after surgery 3078 ±580 to 1665 ±330s p= 0.04) and was no different to controls (2088 ±556s p=0.12) Conclusions Bariatric surgery improved cardiovascular risk parameters to that of the equivalent controls post surgery for weight including EF, hsCRP and LT supporting bariatric surgery as an effective management of obesity.

KW - Endothelial function

KW - Insulin resistance

KW - Obesity

KW - Roux-en-Y surgery

UR - http://www.scopus.com/inward/record.url?scp=84898050271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898050271&partnerID=8YFLogxK

U2 - 10.1007/s11695-013-1100-2

DO - 10.1007/s11695-013-1100-2

M3 - Article

C2 - 24198061

AN - SCOPUS:84898050271

VL - 24

SP - 349

EP - 358

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 3

ER -